Pharmaceutical

Ednaldo Araquém Silva ()
Additional contact information
Ednaldo Araquém Silva: EdgarStat®

Chapter Chapter 6 in U.S. Corporate Profits, 1950–2024, 2026, pp 29-34 from Springer

Abstract: Abstract The pharmaceuticals industry represents another oligopoly, distinct in its reliance on two primary sources of intangibles: research and development (which generates manufacturing intangibles) and advertising, promotion, and detailing (which yield marketing intangibles). These twin pillars, innovation and influence, differentiate the pharmaceutical sector from other manufacturing-intensive industries and create a complex structural profile.

Date: 2026
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:spbchp:978-3-032-11399-3_6

Ordering information: This item can be ordered from
http://www.springer.com/9783032113993

DOI: 10.1007/978-3-032-11399-3_6

Access Statistics for this chapter

More chapters in SpringerBriefs in Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().